Intnl. Biotechnology - Director/PDMR Shareholding
RNS Number : 7783Q Intl. Biotechnology Trust PLC 28 January 2026 INTERNATIONAL BIOTECHNOLOGY TRUST PLC Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Kate Cornish-Bowden | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Director | ||||
| b) | Initial notification/amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | International Biotechnology Trust plc | ||||
| b) | LEI | 213800N1QUJ744P76D11 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 25 pence each ISIN: GB0004559349 | ||||
| b) | Nature of the transaction | Share purchase through non-discretionary dividend reinvestment programme | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price | 265 £2,544.03 | ||||
| e) | Date of the transaction | 27 January 2026 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||
Recent news on International Biotechnology Trust
See all newsRCS - Intnl. Biotechnology - Portfolio company Silence acquired by Merck KGaA
RCS - Intnl. Biotechnology - Investor Presentation via Investor Meet Company
Intnl. Biotechnology - Compliance with Market Abuse Regulation
RCS - Intnl. Biotechnology - QuotedData's In The HotSeat
Intnl. Biotechnology - Director/PDMR Shareholding